BioRestorative Therapies (BRTX) Non Operating Income (2010 - 2025)

BioRestorative Therapies (BRTX) has reported Non Operating Income for 16 consecutive years, with $617664.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Non Operating Income fell 41.4% year-over-year to $617664.0; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (down 45.45% YoY), and the FY2025 full-year result was $1.4 million, down 45.45% from the prior year.
• Non Operating Income declined to $617664.0 in Q4 2025 per BRTX's latest filing, from $670734.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $9.5 million in Q4 2022 and bottomed at -$16.4 million in Q4 2021.
• Historically, Non Operating Income has averaged -$172982.6 across 5 years, with a median of $633344.0 in 2025.
• The sharpest annual moves came in 2022 and 2023: Non Operating Income tumbled 1423.42% in 2022, then surged 840.76% in 2023.
• Over 5 years, Non Operating Income stood at -$16.4 million in 2021, then surged by 157.89% to $9.5 million in 2022, then tumbled by 90.34% to $916688.0 in 2023, then increased by 14.98% to $1.1 million in 2024, then sank by 41.4% to $617664.0 in 2025.
• According to Business Quant data, Non Operating Income over the past three periods registered $617664.0, $670734.0, and $649024.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.